High materiality7/10
Leerink Upgrades Replimune Group (REPL) to Outperform
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Leerink Partners upgrades REPL to Outperform; target $17; price $11.91.
- Leerink Partners upgrades REPL to Outperform; target $17; price $11.91.
Key facts
- 01
Target: $17
- 02
Posted price: $11.91
- 03
Analyst firm: Leerink Partners
- 04
Analyst: Daina Graybosch
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.